Pretreatment frailty is an independent prognostic factor among elderly patients with B-cell lymphoma undergoing immunochemotherapy: A prospective observational cohort study in Taiwan.

Yu-Shin HungHung ChangPo-Nan WangMing-Chung KuoYi-Jiun SuChia-Yen HungShun-Wen HsuehKun-Yun YehYa-Wen HoWen-Chi Chou

Published in: Asia-Pacific journal of clinical oncology (2022)

Frailty significantly influenced the survival outcome as an independent prognostic factor in elderly patients with B-cell lymphoma undergoing immunochemotherapy. Pretreatment frailty assessment is critical to assist clinicians and patients with B-cell lymphoma with prognosis prediction and counseling on an appropriate treatment goal.

Keyphrases

prognostic factors
diffuse large b cell lymphoma
community dwelling
palliative care
antiretroviral therapy